Follow-up study of subjects who participated in the IUGR-1, IUGR-2 and PROGRAM/PREMS study during childhood and early adulthood - Long term effects of growth hormone many years after discontinuatio

Recruiting

• Conditions: cardiovasculaire ziektes; Short children born small for gestational age; 10018424; 10013356

• Registration Number: NL-OMON47841
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 400

Inclusion Criteria

Former participant of the IUGR-1, IUGR-2 or PROGRAM/PREMS study

Exclusion Criteria

Duration of growth hormone treatment less than 4 years

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Insulin resistance</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Blood pressure, body composition, lipid profile, endothelial function and<br /><br>gonadal function.</p><br>